Kim KB - Search Results

1

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.

Falchook GS, Lewis KD, Infante JR, Gordon MS, Vogelzang NJ, DeMarini DJ, Sun P, Moy C, Szabo SA, Roadcap LT, Peddareddigari VG, Lebowitz PF, Le NT, Burris HA 3rd, Messersmith WA, O'Dwyer PJ, Kim KB, Flaherty K, Bendell JC, Gonzalez R, Kurzrock R, Fecher LA. Falchook GS, et al. Among authors: kim kb. Lancet Oncol. 2012 Aug;13(8):782-9. doi: 10.1016/S1470-2045(12)70269-3. Epub 2012 Jul 16. Lancet Oncol. 2012. PMID: 22805292 Free PMC article. Clinical Trial.

2

Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma.

Ballo MT, Gershenwald JE, Zagars GK, Lee JE, Mansfield PF, Strom EA, Bedikian AY, Kim KB, Papadopoulos NE, Prieto VG, Ross MI. Ballo MT, et al. Among authors: kim kb. J Clin Oncol. 2002 Dec 1;20(23):4555-8. doi: 10.1200/JCO.2002.03.002. J Clin Oncol. 2002. PMID: 12454112

3

Biochemotherapy in patients with metastatic anorectal mucosal melanoma.

Kim KB, Sanguino AM, Hodges C, Papadopoulos NE, Eton O, Camacho LH, Broemeling LD, Johnson MM, Ballo MT, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Prieto VG, Bedikian AY. Kim KB, et al. Cancer. 2004 Apr 1;100(7):1478-83. doi: 10.1002/cncr.20113. Cancer. 2004. PMID: 15042682 Free article.

4

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.

Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA, Bedikian AY. Kim KB, et al. Cancer. 2004 Aug 1;101(3):596-603. doi: 10.1002/cncr.20403. Cancer. 2004. PMID: 15274073 Free article.

5

A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.

Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, Camacho LH, Hwu P, Ross MI. Ballo MT, et al. Among authors: kim kb. Ann Surg Oncol. 2004 Dec;11(12):1079-84. doi: 10.1245/ASO.2004.12.039. Ann Surg Oncol. 2004. PMID: 15576833

6

Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma.

Harting MS, Kim KB. Harting MS, et al. Among authors: kim kb. Melanoma Res. 2004 Dec;14(6):517-20. doi: 10.1097/00008390-200412000-00012. Melanoma Res. 2004. PMID: 15577323

7

A phase II trial of arsenic trioxide in patients with metastatic melanoma.

Kim KB, Bedikian AY, Camacho LH, Papadopoulos NE, McCullough C. Kim KB, et al. Cancer. 2005 Oct 15;104(8):1687-92. doi: 10.1002/cncr.21386. Cancer. 2005. PMID: 16130126 Free article. Clinical Trial.

8

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.

Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P. Bedikian AY, et al. J Immunotoxicol. 2008 Apr;5(2):201-7. doi: 10.1080/15476910802131519. J Immunotoxicol. 2008. PMID: 18569391

9

Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim K, Hwu WJ, McIntyre S, Hwu P. Bedikian AY, et al. Cancer Invest. 2008 Jul;26(6):624-33. doi: 10.1080/07357900802027073. Cancer Invest. 2008. PMID: 18584354

10

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Kim KB, et al. Br J Cancer. 2008 Sep 2;99(5):734-40. doi: 10.1038/sj.bjc.6604482. Epub 2008 Aug 19. Br J Cancer. 2008. PMID: 18728664 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,308 results

Search Page